Molecular modelling, synthesis, and biological evaluations of a 3,5-disubstituted isoxazole fatty acid analogue as a PPARα-selective agonist
Open Access
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 27 (18) , 4059-4068
Abstract
No abstract availableKeywords
Funding Information
- Norges Forskningsråd
This publication has 49 references indexed in Scilit:
- Prostaglandins as PPARModulators in AdipogenesisPPAR Research, 2012
- Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reductionCardiovascular Diabetology, 2012
- Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytesJournal of Lipid Research, 2011
- Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytesBiochemical and Biophysical Research Communications, 2011
- Activation of LXR increases acyl-CoA synthetase activity through direct regulation of ACSL3 in human placental trophoblast cellsJournal of Lipid Research, 2010
- The Flexible Pocketome Engine for Structural Chemogenomics2009
- PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acidω‐Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseasePPAR Research, 2009
- LIGAND CONTROL OF COREGULATOR RECRUITMENT TO NUCLEAR RECEPTORSAnnual Review of Physiology, 2005
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive elementBiochemical Journal, 2003